Premium
Development of Generic G Protein Peptidomimetics Able to Stabilize Active State G s Protein‐Coupled Receptors for Application in Drug Discovery
Author(s) -
Mannes Morgane,
Martin Charlotte,
Triest Sarah,
Pia Dimmito Marilisa,
Mollica Adriano,
Laeremans Toon,
Menet Christel J.,
Ballet Steven
Publication year - 2021
Publication title -
angewandte chemie international edition
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 5.831
H-Index - 550
eISSN - 1521-3773
pISSN - 1433-7851
DOI - 10.1002/anie.202100180
Subject(s) - g protein coupled receptor , peptidomimetic , drug discovery , receptor , agonist , g protein , computational biology , biology , chemistry , pharmacology , bioinformatics , biochemistry , peptide
G protein‐coupled receptors (GPCRs) represent an important group of membrane proteins that play a central role in modern medicine. Unfortunately, conformational promiscuity hampers full therapeutic exploitation of GPCRs, since the largest population of the receptor will adopt a basal conformation, which subsequently challenges screens for agonist drug discovery programs. Herein, we describe a set of peptidomimetics able to mimic the ability of G proteins in stabilizing the active state of the β 2 adrenergic receptor (β 2 AR) and the dopamine 1 receptor (D1R). During fragment‐based screening efforts, these (un)constrained peptide analogues of the α 5 helix in G s proteins, were able to identify agonism pre‐imprinted fragments for the examined GPCRs, and as such, they behave as a generic tool, enabling an engagement in agonist earmarked discovery programs.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom